ALPS to Close Three Exchange Traded Funds

Assets managed by the world’s 500 largest fund managers rose by just over 2% in 2014 to reach a new high of $78.1trn, compared to $76.4trn the year before, according to research by global professional services company Towers Watson and Pensions and Investments, a leading U.S. investment newspaper. The Pensions & Investments/Towers Watson World 500 […]

Sir Richard Branson, the boss of the Virgin Group of companies, has offered his private staff as much holiday as they want to take.

UK firm will provide spare engines and parts for US Air Force's Lockheed Martin C-130J Super Hercules fleet.

To celebrate the success of Azizi Bank winning the Finest in Finance - Best Bank in Afghanistan award, Mohammad Salem Omaid, President and CEO writes about this bank’s amazing array of services, plus their emphasis on Corporate Social Responsibility (CSR) activities, as well as women’s emancipation in the workplace.

For a long time, people who do banking, loans, insurance, and other financial activities daily wished these transactions would improve by the day and be more efficient. In today’s fast-paced world, making your transactions efficient and easier is best. It’s why many people think artificial intelligence is a big help to make these things better. […]

Scotch whisky is a symbol of British craftsmanship and tradition, of durability and reliability. And though it hasn’t been around for ever, it has been recognised throughout history. Its documented story begins in 1494, and tax records of the day show that a friar acquired eight bolls – about 2,500lbs – of malted barley, “wherewith to make aqua vitae”.

'Trust Capital' is now the '4th C' of organisational value - alongside Human, Financial and Intellectual Capital - and a key factor for consumers in making brand choices

In seven years from creation, the fintech company Capital on Tap, celebrates a major milestone of lending over 1 billion pounds to more than 65,000 small and medium enterprise businesses across the UK.

NephroGenex, Inc., a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that it has commenced an underwritten public offering of shares of its common stock and expects to raise gross proceeds of up to $30 million. In addition, NephroGenex expects to grant the underwriters a 30-day option to purchase up to an additional $4.5 million of shares of its common stock in connection with the offering. All of the shares in the offering will be sold by NephroGenex.

Outsourcing is a business practice in which you contract with an external party in order for them to take care of specific tasks as opposed to hiring fresh staff or assigning those tasks to your existing staff. It’s quite a popular method for businesses to lower their costs for operation and to streamline those operations […]